Aurobindo Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406A01037
  • NSEID: AUROPHARMA
  • BSEID: 524804
INR
1,795.30
-11.7 (-0.65%)
BSENSE

Nov 20

BSE+NSE Vol: 8.25 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 164981,
    "name": "Aurobindo Pharma",
    "stock_name": "Aurobindo Pharma",
    "full_name": "Aurobindo Pharma Ltd.",
    "name_url": "stocks-analysis/aurobindo-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,795.30",
    "chg": -11.7,
    "chgp": "-0.65%",
    "dir": -1,
    "prev_price": "1,807.00",
    "mcapval": "103,795.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 524804,
    "symbol": "AUROPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE406A01037",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "8.25 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/aurobindo-pharma-164981-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Aurobindo Pharma Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/aurobindo-pharma-ltd-is-rated-hold-by-marketsmojo-4269050",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AurobindoPharma_mojoScore_4269050.png",
        "date": "2026-11-20 10:11:27",
        "description": "Aurobindo Pharma Ltd. is currently rated 'Hold' by MarketsMOJO, a rating that was last updated on 25 May 2026. While this rating adjustment occurred several months ago, the analysis and financial metrics presented here reflect the stock's current position as of 20 November 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Aurobindo Pharma Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aurobindo-pharma-sees-significant-open-interest-surge-amid-mixed-market-signals-4268517",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AurobindoPharma_oi_spurts_by_underlying_4268517.png",
        "date": "2026-11-19 15:00:08",
        "description": "Aurobindo Pharma Ltd. has witnessed a notable 10.57% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal decline in the stock price and subdued volume, the surge in open interest suggests that traders are recalibrating their directional bets amid a complex market backdrop."
      },
      {
        "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amidst Narrow Price Range",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amidst-narrow-price-range-4267221",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AurobindoPharma_oi_spurts_by_underlying_4267221.png",
        "date": "2026-11-18 15:00:09",
        "description": "Aurobindo Pharma Ltd. has witnessed a notable 13.9% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite trading close to its 52-week high, the stock’s mixed volume and delivery trends suggest cautious optimism among traders navigating the pharmaceuticals sector."
      },
      {
        "title": "Aurobindo Pharma Sees Significant Open Interest Surge Amid Derivatives Activity",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aurobindo-pharma-sees-significant-open-interest-surge-amid-derivatives-activity-4267144",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AurobindoPharma_oi_spurts_by_underlying_4267144.png",
        "date": "2026-11-18 14:00:09",
        "description": "Aurobindo Pharma Ltd. has witnessed a notable 13.46% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 0.53% gain in the stock price, the pharmaceutical mid-cap’s recent trading patterns and volume dynamics suggest a complex interplay of bullish and cautious sentiment among traders."
      },
      {
        "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Signalling Renewed Market Interest",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-signalling-renewed-market-interest-4267103",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AurobindoPharma_oi_spurts_by_underlying_4267103.png",
        "date": "2026-11-18 13:00:08",
        "description": "Aurobindo Pharma Ltd. has witnessed a notable surge in open interest in its derivatives segment, signalling increased market activity and evolving investor positioning. Despite a modest price gain and narrowing trading range, the pharmaceutical mid-cap’s recent volume and open interest dynamics suggest a complex interplay of bullish and cautious bets among traders."
      },
      {
        "title": "Aurobindo Pharma Sees Significant Open Interest Surge Amid Narrow Price Movement",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aurobindo-pharma-sees-significant-open-interest-surge-amid-narrow-price-movement-4265672",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AurobindoPharma_oi_spurts_by_underlying_4265672.png",
        "date": "2026-11-17 15:00:06",
        "description": "Aurobindo Pharma Ltd. has witnessed a notable 10.3% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite trading close to its 52-week high, the stock’s mixed volume patterns and falling investor participation suggest a complex outlook for this mid-cap pharmaceutical player."
      },
      {
        "title": "Aurobindo Pharma Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/aurobindo-pharma-ltd-is-rated-hold-by-marketsmojo-4256600",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AurobindoPharma_mojoScore_4256600.png",
        "date": "2026-11-09 10:10:56",
        "description": "Aurobindo Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 November 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1819.3",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-of-rs18193-on-9-nov-2026-4256464",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AurobindoPharma_priceRelatedfactors_4256464.png",
        "date": "2026-11-09 09:40:10",
        "description": "Surging past Rs 1819.3 on 09 Nov 2026, Aurobindo Pharma Ltd. has marked a significant milestone by reaching a fresh 52-week high, propelled by a sustained 12-day rally that has delivered a 15.43% gain. This performance notably outpaces the broader Sensex, which slipped 0.18% on the same day, underscoring the stock's robust momentum within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Aurobindo Pharma Gains 7.10%: 6 Key Factors Driving the Week’s Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aurobindo-pharma-gains-710-6-key-factors-driving-the-weeks-momentum-4256256",
        "imagepath": "",
        "date": "2026-11-08 15:00:40",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 2:</strong> Technical momentum shifts signal bullish outlook</p>\n                    <p><strong>Nov 5:</strong> New 52-week high at Rs.1,748.85 and intraday peak of Rs.1,785.5</p>\n                    <p><strong>Nov 5:</strong> Strong quarterly growth upgrades financial trend to positive</p>\n                    <p><strong>Nov 6:</strong> New 52-week high at Rs.1,805 despite slight daily dip</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,677.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=..."
      }
    ],
    "total": 179,
    "sid": "164981",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/aurobindo-pharma-164981"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "19-Nov-2026",
      "details": "Submission of copy of notice published in newspapers.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "18-Nov-2026",
      "details": "Submission of Postal Ballot Notice.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "11-Nov-2026",
      "details": "Submission of Earning Call Transcript for Q2FY27.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has declared <strong>700%</strong> dividend, ex-date: 11 Nov 26",
          "dt": "2026-11-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:5</strong> stock split, ex-date: 10 Feb 11",
          "dt": "2011-02-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 20 Jul 15",
          "dt": "2015-07-20",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

19-Nov-2026 | Source : BSE

Submission of copy of notice published in newspapers.

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

18-Nov-2026 | Source : BSE

Submission of Postal Ballot Notice.

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

11-Nov-2026 | Source : BSE

Submission of Earning Call Transcript for Q2FY27.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Aurobindo Pharma Ltd. has declared 700% dividend, ex-date: 11 Nov 26

stock-summary
SPLITS

Aurobindo Pharma Ltd. has announced 1:5 stock split, ex-date: 10 Feb 11

stock-summary
BONUS

Aurobindo Pharma Ltd. has announced 1:1 bonus issue, ex-date: 20 Jul 15

stock-summary
RIGHTS

No Rights history available